Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 11, Novembre 2011
Page(s) 929 - 931
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20112711005
Publié en ligne 30 novembre 2011
  1. Duclos-Vallée JC, Teicher E, Vittecoq D, Samuel D. La transplantation hépatique chez les patients co-infectés VIH/VHC et VIH/VHB. Med Sci (Paris) 2007 ; 23 : 723–728. [CrossRef] [EDP Sciences] [PubMed]
  2. Lindenbach BD, Thiel HJ, Rice CM. Flaviviridae, the viruses and their replication. Philadelphia : Lippincott-Raven , 2007 : 1101–1152.
  3. Zeisel MB, Fofana I, Fafi-Kremer S, et al. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 2011 ; 54 : 566–576. [CrossRef] [PubMed]
  4. Tews BA, Cocquerel L. Occludine, une clé de plus pour l’entrée du virus de l’hépatite C. Med Sci (Paris) 2009 ; 25 : 549–551. [CrossRef] [EDP Sciences] [PubMed]
  5. Harris HJ, Farquhar MJ, Mee CJ, et al. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol 2008 ; 82 : 5007–5020. [CrossRef] [PubMed]
  6. Krieger SE, Zeisel MB, Davis C, et al. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 2010 ; 51 : 1144–1157. [CrossRef] [PubMed]
  7. Blanchard E, Belouzard S, Goueslain L, et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 2006 ; 80 : 6964–6972. [CrossRef] [PubMed]
  8. Pelkmans L, Fava E, Grabner H, et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 2005 ; 436 : 78–86. [CrossRef] [PubMed]
  9. Farquhar MJ, Harris HJ, Diskar M, et al. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J Virol 2008 ; 82 : 8797–8811. [CrossRef] [PubMed]
  10. Trotard M, Lepère-Douard C, Régeard M, et al. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J 2009 ; 23 : 3780–3789. [CrossRef] [PubMed]
  11. Lupberger J, Zeisel MB, Xiao F, et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 2011 ; 17 : 589–595. [CrossRef] [PubMed]
  12. Reiss S, Rebhan I, Backes P, et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011 ; 9 : 32–45. [NASA ADS] [CrossRef] [EDP Sciences] [MathSciNet] [PubMed]
  13. Gerold G, Rice CM. Locking out hepatitis C. Nat Med 2011 ; 17 : 542–544. [CrossRef] [PubMed]